Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Clinical Trials Facilitation and Coordination Group | Statement: [HMA, hasWorkingGroup, Clinical Trials Facilitation and Coordination Group]

Target entity: Clinical Trials Facilitation and Coordination Group
Context triple: [HMA, hasWorkingGroup, Clinical Trials Facilitation and Coordination Group]

• A. Center for Clinical Standards and Quality
  The Center for Clinical Standards and Quality is a division of the U.S. federal health system responsible for developing, implementing, and enforcing national healthcare quality and safety standards across Medicare- and Medicaid-participating providers.
• B. Committee for Advanced Therapies
  The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
• C. Centre for Collaboration with Registry Networks
  The Centre for Collaboration with Registry Networks is a specialized unit within Norway’s public health system that coordinates and advances the use of health registries for research, surveillance, and policy development.
• D. NCI-Designated Cancer Centers Program
  The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
• E. Patient-Centered Outcomes Research Institute
  The Patient-Centered Outcomes Research Institute is an independent, nonprofit organization in the United States that funds and promotes comparative clinical effectiveness research to help patients and clinicians make better-informed healthcare decisions.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Clinical Trials Facilitation and Coordination Group
Triple: [HMA, hasWorkingGroup, Clinical Trials Facilitation and Coordination Group]

The Clinical Trials Facilitation and Coordination Group is a working group under the Heads of Medicines Agencies that focuses on harmonizing and streamlining clinical trial assessment and regulation across European countries.

Target entity: Clinical Trials Facilitation and Coordination Group
Target entity description: The Clinical Trials Facilitation and Coordination Group is a working group under the Heads of Medicines Agencies that focuses on harmonizing and streamlining clinical trial assessment and regulation across European countries.

• A. Center for Clinical Standards and Quality
  The Center for Clinical Standards and Quality is a division of the U.S. federal health system responsible for developing, implementing, and enforcing national healthcare quality and safety standards across Medicare- and Medicaid-participating providers.
• B. Committee for Advanced Therapies
  The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
• C. Centre for Collaboration with Registry Networks
  The Centre for Collaboration with Registry Networks is a specialized unit within Norway’s public health system that coordinates and advances the use of health registries for research, surveillance, and policy development.
• D. NCI-Designated Cancer Centers Program
  The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
• E. Patient-Centered Outcomes Research Institute
  The Patient-Centered Outcomes Research Institute is an independent, nonprofit organization in the United States that funds and promotes comparative clinical effectiveness research to help patients and clinicians make better-informed healthcare decisions.
• F. None of above. chosen